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Abstract
Adverse drug reactions (ADRs) are undesirable and
potentially fatal outcomes resulting from the use
of medications. The possibility of experiencing
an ADR varies between individuals owing to dis-
ease heterogeneity, genetic and demographic fac-
tors, patient treatment history and disease trajecto-
ries. Therefore, understanding the interplay among
the multiple factors leading to ADRs is crucial to
increasing drug effectiveness, individualising drug
therapy and reducing incurred cost.
In this paper, we present the first step towards
predicting ADRs based on patient profiles and
treatment trajectories hidden within the Electronic
Health Records (EHRs). We propose a flexible
encoding mechanism that can effectively capture
the dynamics of multiple medication episodes of
a patient at any given time. We enrich the en-
coding with a drug ontology and patient demo-
graphics data and use it as a base for an ADR
prediction model. We evaluate the resulting pre-
dictive approach under different settings using real
anonymised patient data obtained from the EHR
of the South London and Maudsley (SLaM), the
largest mental health provider in Europe. Using the
profiles of 38,000 mental health patients, we iden-
tified 240,000 affirmative mentions of dry mouth,
constipation and enuresis and 44,000 negative ones.
Our approach achieved 93% prediction accuracy
and 93% F-Measure. Overall, we found that us-
ing our encoding can improve prediction accuracy
by 10% compared to static medication modelling
settings.
1 Introduction
Adversities associated with prescribed mediation can seri-
ously affect the patient’s wellbeing [Edwards and Aron-
son, 2000] and present a real financial burden on healthcare
providers (estimated to lead to an annual cost of 466 mil-
lion pounds in the United Kingdom alone [Pirmohamed et
al., 2004]). The problem arises from the fact that trial-tested
prescribed drugs are not evaluated for long-term effectiveness
in diverse (and possibly comorbid) patient populations, re-
sulting in many unknowns with respect to the possibilities of
the onset of adverse drug reactions (ADRs). Currently, dis-
covering the factors affecting patients’ response to treatment
relies on spontaneous reporting systems that rely on patient
and clinician data entry and resulting highly under-reported
ADR instances [Tatonetti et al., 2012]. However, there is a
large body of unutilised knowledge embedded in the Elec-
tronic Health Records (EHRs) of hospitals, containing valu-
able information regarding treatment responses as well as pa-
tient profiles and disease trajectories. Therefore, there is an
immediate use case for automating the ability to mine, and
eventually predict, the onset of ADRs from EHRs in order to
enable healthcare professionals to choose the most appropri-
ate medication for a particular patient.
Many factors can lead to the onset of ADRs, ranging
from patient habits (such as smoking or alcohol intake) to
demographics, comorbidities, genetic dispositions and other
prescribed (and non-prescribed) medications. For example,
Clozapine, a typical antipsychotic drug, might cause dizzi-
ness or nausea among other 240 side effects, whereby the
pathology of these side effects is multifactorial and mostly
unknown [Kuhn et al., 2015]). Analysing the factors asso-
ciated with ADRs using EHRs resolves to the task of uncov-
ering the temporal associations connecting the different fac-
tors. Things are more complicated in long-term debilitating
and comorbidity illnesses whereby ADRs are associated with
multiple, overlapping and long medication episodes. From a
technical perspective, a challenging task lies in modelling the
time series of medication episodes in an effective way so that
they can be fed with other influencing factors into predictive
algorithms.
In this paper, we propose a bitwise encoding mechanism
that can capture the temporal precedence and duration in-
formation of medication episodes as well as their distance
from the time of inspection. The encoding method presented
is flexible for enrichment with additional mined knowledge
and external ontologies and can be readily used by off-the-
shelf machine learning algorithms. We show how a predictive
model can be formed using the presented encoding, combined
with mined patient demographics (age, gender and ethnicity)
as well as an external (drug) ontology to anticipate ADR onset
(Figure 1). We present an initial study of using the resulting
model to predict the onset of three ADRs, mainly dry mouth,
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Figure 1: Building Blocks of the Prediction Model
constipation and enuresis, from a large mental health register.
Various approaches have been proposed for modelling sim-
ilar healthcare events. [Sun et al., 2012] proposed count-
ing the frequencies in certain time periods to capture discrete
temporal features. While such models are simple and effi-
cient enough for later analysis, they are missing some critical
information for ADR models such as the continuous nature
of medication episodes and the distances of events to the time
of inspection. In contrast to these simple approaches, graph-
based models [Liu et al., 2015] capture the temporal orders
corresponding intervals. While these models can convey most
needed information, they are not easy to digest for many off-
the-shelf learning algorithms.
In addition, EHR-embedded temporal events have been
studied for various reasons: [Monroe et al., 2013] studied the
temporal event sequence simplification for visualisation pur-
poses; [Zhou et al., 2014; Liu et al., 2015; Sun et al., 2012]
examined various approaches to model temporal events for
patients stratification or personalised medicine. Our encod-
ing mechanism complements existing solutions with features
making it more effective in modelling medication episodes
for adverse event prediction.
The paper is structured as follows. After detailing the en-
coding system and proposed multi-factorial predictive model
in Section 2, we show the results of applying the model to
predict the three ADRs. We conclude by summarising our
work and outlining future directions in Section 4.
2 Temporal Encoding for Patient’s
Medication Episodes
Here, we present the novel vector-based encoding of dynamic
and multiple medication episodes. Figure 2 illustrates an ex-
ample encoding scenario. The upper part shows the sample
medication episodes of a patient that are related to a certain
inspecting time spot (marked as AE date in the figure). The
encoding is realised through the following steps.
1. From the the inspecting time spot, look back to a certain
period of time, e.g., 20 days. In our experiments, we
selected 30 days.
2. Split the time period into intervals using a unit of time,
e.g., a day or a week. Number each interval in an ascen-
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Figure 2: The bitwise encoding of dynamic medication
episodes for a given adverse event
dent order (started from zero) starting from the inspect-
ing time spot. For example, 4 intervals are identified and
numbered in Figure 2
3. Add the patient’s medication episodes to the timeline.
4. For each medication episode, allocate a sequence of bits
aligned with the interval order we obtained in step 2.
The interval numbered zero is aligned with the most sig-
nificant bit in the sequence. For each interval, set the
corresponding bit to 1 if the interval intersects with the
episode, and to 0 otherwise. For example, Medication
Episode 2 (M2) in Figure 2 spans across interval num-
ber 1 and 2. Its encoding is 0110 in binary code.
5. Repeat step 4 for all medication episodes. We will get a
vector representing all the relevant medication episodes
of the inspecting time spot.
The resulting bitwise encoding has the following features:
• Simple and Succinct: Each medication episode is repre-
sented as a numeric value which can used as the feature
value in a predictive model which can be consumed by
most machine learning algorithms.
• Informative: The encoded number conveys both the du-
ration information of an episode (i.e. occurrences across
multiple time intervals are recorded in their correspond-
ing bits) and also the distances of each occurrence (i.e.,
the orders of bits in the number). For example, for du-
ration, M2 crosses two intervals and its encoded number
has two bits set as 1 accordingly; for distances, M1 and
M3 are both present in only one interval. However, M3
is encoded as 8 because it is closer to the event, while
M1 is represented as 1.
• Flexible Different units of time can be used in step 2,
enabling variable levels of granularity. For example, if
the unit used is 4 times bigger in Figure 2, all three med-
ication episodes will be encoded as 1. The same number
of bits can cover medication periods that are four folds
longer. The obvious loss of information however must
be taken into account when choosing a time unit.
2.1 Predictive Model
Having illustrated the encoding of the temporal information
embedded within medication episodes, we now show how
this information can be combined with additional background
knowledge as well as external ontologies into a feature vector
for prediction.
Our predictive model considers two sets of features: 1) de-
mographics, 2) the generated dynamic medication episodes
which are further enriched by an ontology. Equation 1 shows
the features of demographic information of a patient p at a
given time t where age@t means the patient’s age at the in-
specting time t.
Fd(p, t) = (age@t, gender, ethnicity) (1)
Equation 2 gives the feature calculation from dynamic
medication episodes given a patient p, an adverse event type
a and a time t.
Fm(p, a, t) = (α · diag(~Sa) + diag(~1)) · ~Mp,t (2)
~Sa is a binary vector describing drugs’ relation with side
effect a. For example, suppose there are two drugs (d1, d2),
and d1 has the side effect a but d2 does not. Then, the ~Sa is
[1, 0]. Such vector is derived from the drug ontology. ~Mp,t
is the vector generated from the medication episodes of the
patient p at a given time t using our encoding method. α
is the weighting factor for adjusting side effect knowledge
importance in the final prediction model.
The final feature vector for prediction is a concatenation of
the above two as shown in equation 3. In this paper, we view
the ADR prediction as a classification problem. Therefore,
the feature vector is used as the inputs for training and testing
classification algorithms on our datasets. Various classifiers
have been tested. The experiment section will give the detail
about model selection.
F (p, a, t) = (Fm(p, a, t), Fd(p, t)) (3)
3 Implementation and Evaluation
3.1 Data Source
We used data extracted from the Clinical Record Interac-
tive Search System (CRIS) [Stewart et al., 2009] to eval-
uate our encoding. CRIS is a database containing a de-
identified replica of the EHRs used by the South London
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Figure 3: Drug Ontology for AE Prediction
and Maudsley Foundation Trust (SLaM), the largest mental
health provider in Europe. SLaM serves over 1.2 million pa-
tients and stores much of its clinical records and prescribing
information in unstructured free text format. As of October
2015, CRIS contains over 240,000 patient records comprised
of over 22,270,000 free text documents including correspon-
dence, discharge summaries, events, mental health care plan
and mental state formulations [Stewart et al., 2009].
As most of the ADR and drug episode information is
recorded unstructured free-text, we used in-house developed
natural language processing tools in conjunction with man-
ual annotation to extract and structure relevant information
[Iqbal et al., 2015]. As we will show later, over 62 per cent
of identified ADRs in our data are associated with multiple
medication episodes.
3.2 Drug Ontology
In the EHRs, various drug naming or ID systems are simulta-
neously used. For example, in our data, a single drug maybe
referred to by its generic drug name (e.g., Clozapine) or trade
names (e.g., Clozaral or Denzapine). Using a consistent rep-
resentation of drug names will give us the ability to reduce
unnecessary (semantically) duplicated features in our predic-
tion model, which can lead to significant performance differ-
ences in (at least certain) machine learning algorithms. Fur-
thermore, grouping drugs based on their functions or effects
will enhance our ability to further abstract the medications.
There exist many publicly available resources containing
drug knowledge, such as DrugBank [Wishart et al., 2006] and
Drug Ontology1, as well as mental health-specific drug in-
formation, e.g., Psychology Ontology2. By inspecting these
resources with clinicians and pharmacists, we found it un-
avoidable to populate our own drug ontology based on (some
of) the available resources. This is because off-the-shelf re-
sources provide insufficient information to map psychiatric
drug IDs used in the EHRs to their generic names as these
resources: a) do not contain some of the trade names used in
the EHRs; b) are not populated with information about new
antipsychotic drugs.
1https://ontology.atlassian.net/wiki/
display/DRON/Drug+Ontology+Home
2http://bioportal.bioontology.org/
ontologies/APAONTO
We identified 369 drug IDs in our EHR system, which we
mapped to 240 generic names. We further categorised these
drugs via a two-layer system comprising of a primary and a
secondary category as shown in Figure 3. When a generic
drug does not have a secondary category, it is typed directly
by its primary category, e.g., Lithium is typed as Mood Sta-
biliser that is a primary category.
In addition to drug hierarchy, the known side effects of
a drug are important knowledge that is crucial to ADR pre-
diction. We further enriched our ontology with side effect
knowledge extracted from SIDER [Kuhn et al., 2015].
3.3 Dataset Preparation and Classifier Selection
In this preliminary study, we focus on three types of adverse
events identified in the CRIS registry: dry mouth (#event
58,347), constipation (#event 86,602) and enuresis (#93,366),
which involves 20,795 distinct patients with mental health
disorders. For each identified AE, we pick up the patient’s
past 30 days medication episodes. Since we are particularly
interested in AEs that are associated with dynamic and mul-
tiple medication episodes, it would be helpful to understand
how often such situations happen in real data. As shown in
Figure 4, a fairly large proportion (≥ 62% on average) of AEs
are associated with multiple medications.
To generate negative data items (none adverse event), we
picked 18,038 patients who have medication episode data in
CRIS registry but never had the three types of adverse events
reported. We generate a negative data item for each medi-
cation episode. For the same patient, if there are multiple
episodes with the same end date, these data items will be
merged into one. But how to set the event dates for these
negative data items is very interesting considering that an ad-
verse event might happen days after a medication episode.
We will show some experiment results on different ways of
setting such dates. About 44,900 negative data items were
generated in this study.
The dataset was split into a proportion of 80/20 for training
and testing. 10-folds cross validation has also been used. The
former setting achieved better performance across three AE
types.
We have tried various classification models including
Naı¨ve Bayesian, Bayesian Network and different decision
trees. Among these models, Bayesian Network achieved the
best performance in our dataset considering the accuracy and
efficiency. For Bayesian Network training, different settings
have been tried on search algorithms used in the model in-
cluding: a) the inclusion or exclusion of using Markov Blan-
ket correction on the learned network and b) various setting
of maximum number of parent nodes. No performance differ-
ence was observed between options in setting a. For setting
b, the classification accuracy increases along with the maxi-
mum number of parents from 1 to 4. In all three AE case, the
performance climbs to its highest when the number is set as 4
and it decreases thereafter. However, the improvements from
1 to 4 are not significant. The biggest difference in all three
cases is 0.9% in Enuresis case.
32.79%	
39.30%	 39.56%	
67.21%	
60.70%	 60.44%	
Dry	Mouth	 Cons8pa8on	 Enuresis	
1	Medica8on	Episode	 ≥1Medica8on	Episodes	
Figure 4: #AEs: Single vs Multiple Medication-episodes
86.17% 
88.41% 
92.99% 
81.34% 
83.64% 
91.76% 
77.81% 
83.01% 
90.24% 
30d 10d 1d 
Dry Mouth Constipation Enuresis 
Figure 5: Encoding performance (average classification ac-
curacy): the effect of time length represented by a bit (com-
pression ratio)
3.4 Demographic vs Medication Episode Features
We have two types of feature sets - demographic features and
medication episode ones. Comparing their performances will
reveal some insights about what factors are more likely to be
associated with adverse events. Table 1 shows the detail of
demographic feature only results. In general, the F-Measure
is around 70%. But for AE class of dry mouth type, the per-
formance is extremely low - 12% True Positive and 20% F-
Measure. Table 2 gives the performance of dynamic medi-
cation episode features. In all cases, about 90% F-Measure
has been achieved with the lowest at 85% at AE class of dry
mouth and the highest at 96% at none AE class of the same
case. In summary, it is quite obvious that dynamic medica-
tion episode features are much better indicators for predicting
Adverse Events. The combination of the two sets of features
can achieve the best results as shown in Table 3. Both average
Precision and F-Measure are around 93%.
3.5 Different Settings in Dynamic Medication
Episode Encoding
In the bitwise encoding of medication episodes, the length of
time interval represented by a bit might lead to different lev-
els of abstractions that encoding represents. In other words,
this setting is a kind of compression ratio of the encoding -
the longer the more information loss. In the extreme setting,
the whole period is represented by a bit. In this situation, the
dynamic information (length of episode and their distances
to the inspecting time) of medications is lost. In Figure 5, we
compared three settings - a bit representing 1 day, 10 days and
30 days. 1-day setting got the best performance. In general,
ADE Type TP Rate FP Rate Precision Recall F-Measure ROC Area Class
Dry Mouth 0.12 0.02 0.64 0.12 0.2 0.731 AE0.98 0.88 0.79 0.98 0.87 0.73 N-AE
Weighted Avg. 0.78 0.68 0.75 0.78 0.72 0.73
Constipation 0.74 0.40 0.63 0.74 0.68 0.74 AE0.60 0.26 0.72 0.60 0.65 0.74 N-AE
Weighted Avg. 0.67 0.33 0.68 0.67 0.67 0.74
Enuresis 0.82 0.40 0.70 0.82 0.75 0.78 AE0.60 0.18 0.76 0.60 0.67 0.78 N-AE
Weighted Avg. 0.72 0.29 0.72 0.72 0.71 0.78
Table 1: Demographic-Feature Only Results
ADE Type TP Rate FP Rate Precision Recall F-Measure ROC Area Class
Dry Mouth 0.83 0.04 0.86 0.83 0.85 0.97 AE0.96 0.17 0.95 0.96 0.96 0.97 N-AE
Weighted Avg. 0.93 0.14 0.93 0.93 0.93 0.97
Constipation 0.90 0.07 0.92 0.90 0.91 0.97 AE0.93 0.10 0.91 0.93 0.92 0.97 N-AE
Weighted Avg. 0.92 0.08 0.92 0.92 0.92 0.97
Enuresis 0.88 0.07 0.93 0.88 0.90 0.96 AE0.93 0.12 0.88 0.93 0.90 0.96 N-AE
Weighted Avg. 0.90 0.10 0.90 0.90 0.90 0.96
Table 2: Medication Episode-Feature Only Results
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Figure 6: Feature Dimension Reduction by Drug Ontology
the smaller the granularity the better performance. Compared
to the 30-day setting, 1-day setting can achieve up to 12%
better performance. This concludes that the dynamic nature
of the medication episodes is a very important factor associ-
ated with adverse events and the bitwise encoding can capture
such information effectively.
3.6 Ontology-based Feature Dimension Reduction
The semantics in the drug ontologies can be utilised to com-
bine semantically similar drugs so that the dimensions of the
feature vector Fm (Equation 2) can be reduced significantly
(from 226 for all drugs to 47 for using direct parent category).
The performance differences between these two settings are
illustrated in Figure 6. For dry mouth and constipation cases,
the performances (average classification accuracy) decreased
in about 1 per cent in average when using drug classes, while
the accuracy did improve in the enuresis case when the fea-
ture dimension was reduced. This is a very interesting obser-
vation worth further investigation to see whether it is a single
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Figure 7: The Effect of Date Settings of None AE data items
special case or the drugs related to enuresis make the case
special. Figure 6 also reveals that using less feature dimen-
sion can significantly increase the training speed, which is not
surprising.
3.7 The event time settings for negative data items
As discussed in section 3.3, when populating the negative
data items (none AE data items) we need to decide which
date to use for setting the date of the item. Figure 7 shows
the results of different settings we tried. The date settings are
based on the offset of the medication episode that is used to
generate the data item. Three settings have been tested: 0-
offset means using the end date of the medication episode,
rnd-10 offset means randomly picking a number from 1 to
10 then adding it (as days) to the medication end date to get a
new date and using it, and finally rnd-30 offset is the same but
using a random number from 1 to 30. Rnd-30 offset gets best
performance (classification accuracy) in dry mouth and con-
ADE Type TP Rate FP Rate Precision Recall F-Measure ROC Area Class
Dry Mouth 0.89 0.05 0.85 0.89 0.87 0.98 AE0.95 0.11 0.97 0.95 0.96 0.98 N-AE
Weighted Avg. 0.94 0.10 0.94 0.94 0.94 0.98
Constipation 0.93 0.08 0.91 0.93 0.92 0.97 AE0.92 0.08 0.93 0.92 0.93 0.97 N-AE
Weighted Avg. 0.92 0.08 0.92 0.92 0.92 0.97
Enuresis 0.92 0.09 0.92 0.92 0.92 0.96 AE0.91 0.08 0.91 0.91 0.91 0.96 N-AE
Weighted Avg. 0.92 0.08 0.92 0.918 0.92 0.96
Table 3: Medication Episode and Demographic Combined Results
stipation, while the enuresis case gets the best performance at
rnd-10 setting. Due the the significant performance decrease
in enuresis in rnd-30 setting, we generally use rnd-10 offset
in our model.
4 Conclusion
We reported a retrospective study of predicting adverse events
in EHRs from South London and Maudsley Foundation Trust
(SLaM), the largest mental health provider in Europe. In
addition to demographic patient information (e.g., age, gen-
der and ethnicity) and drug related knowledge (e.g., cat-
egorisation and side effects), the prediction model puts a
special focus on effective approaches of modelling the dy-
namic and multiple medication episodes, which are very com-
mon among patients with mental health disorders (observed
among ≥ 62% events in our data). Specifically, a novel bit-
wise encoding approach is introduced for capturing the med-
ication trajectories, which has proved to be more effective
(10% accuracy improvement) than static medication mod-
elling settings. Experimental results show that the medication
episodes are much better indicators than demographic infor-
mation for predicting adverse events, while the best perfor-
mance (93% in both precision and F-Measure) was obtained
by combining these two. From the evaluation, we also ob-
served mixed performance changes when reducing the feature
dimension by using the drug ontology hierarchy - prediction
accuracies decreased slightly in two cases but increased in
another. This is an interesting phenomenon that we plan to
investigate in detail in our ongoing work.
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